VIKING THERAPEUTICS ANNOUNCES POSITIVE TOPLINE RESULTS FROM MAINTENANCE STUDY OF GLP-1/GIP AGONIST VK2735 DEMONSTRATING THE PROMISE OF MULTIPLE MAINTENANCE DOSING REGIMENS

Observed price moves

• VKTX+29.58%10 min after this headline

MoveSurge carries market-moving headlines the moment they reach the wire, each one with what the price did next.